ADAPTIVE BIOTECHNOLOGIES CORPORATION Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-06-22: Form 8-K; Exhibit 10.2; Description Waiver Agreement, dated as of June 15, 2026, among Adaptive Biotechnologies Corporation, OrbiMed Royalty & Credit Opportunities IV, LP, OrbiMed Royalty & Credit Opportunities III, LP and OrbiMed Royalty & Credit Opportunities IV Offshore, LP.
- 2026-06-22: Form 8-K; Exhibit 10.1; Description Form of Capped Call Confirmation.
- 2026-05-05: Form 10-Q; Exhibit 10.1; Description Form of Performance Units Agreement and Notice of Grant of Performance Units.
- 2025-08-05: Form 10-Q; Exhibit 10.10; Description Non-Employee Director Compensation Policy.
| Filed | Form | Exhibit | Description |
|---|
| 2026-06-22 | 8-K | 10.2 | Waiver Agreement, dated as of June 15, 2026, among Adaptive Biotechnologies Corporation, OrbiMed Royalty & Credit Opportunities IV, LP, OrbiMed Royalty & Credit Opportunities III, LP and OrbiMed Royalty & Credit Opportunities IV Offshore, LP |
|---|
| 2026-06-22 | 8-K | 10.1 | Form of Capped Call Confirmation |
|---|
| 2026-05-05 | 10-Q | 10.1 | Form of Performance Units Agreement and Notice of Grant of Performance Units |
|---|
| 2025-08-05 | 10-Q | 10.10 | Non-Employee Director Compensation Policy |
|---|
| 2024-04-09 | 8-K | 10.1 | Executive Employment Agreement between the Company and Kyle Piskel dated April 4, 2024 |
|---|
| 2023-02-14 | 10-K | 10.10 | Adaptive Biotechnologies Corporation Non-Employee Director Compensation Policy |
|---|
| 2022-09-12 | 8-K | 10.1 | Revenue Interest Purchase Agreement, made and entered into as of September 12, 2022, by and among Adaptive Biotechnologies Corporation, the Purchasers from time to time party hereto, and OrbiMed Royalty & Credit Opportunities IV, LP |
|---|
| 2022-05-04 | 10-Q | 10.1 | Form of Performance Units Agreement and Notice of Grant of Performance Units |
|---|
| 2021-02-24 | 10-K | 10.17 | Form of Restricted Stock Unit Agreement for Non-U.S Participants |
|---|
| 2021-02-24 | 10-K | 10.16 | Form of Stock Option Agreement for Non-U.S Participants |
|---|
| 2021-02-24 | 10-K | 10.12 | Adaptive Biotechnologies Corporation Non-Employee Director Compensation Policy |
|---|
| 2020-08-10 | 10-Q | 10.1 | Form of Executive Severance Agreement between Adaptive Biotechnologies Corporation and certain of its executive officers |
|---|
| 2019-11-12 | 10-Q | 10.3 | IVD Test Kit Development and Supply Agreement between Illumina, Inc. and Adaptive Biotechnologies Corporation, effective September 23, 2019 |
|---|
| 2019-08-13 | 10-Q | 10.12 | Adaptive Biotechnologies Corporation 2019 Equity Incentive Plan and form of award agreement thereunder |
|---|
| 2019-08-07 | 8-K | 10.2 | Lease Agreement between Adaptive Biotechnologies Corporation and ARE-Seattle No. 12, LLC, dated August 2, 2019 |
|---|
| 2019-08-07 | 8-K | 10.1 | Sixth Amendment to Lease Agreement between Adaptive Biotechnologies Corporation and ARE-Seattle No. 11, LLC, dated August 2, 2019 |
|---|